SCHEMBL7014203

SCHEMBL7014203

Cc1ccc(-c2cccc(-c3noc(C(Cl)(Cl)Cl)n3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.51
RAB9A P51151 11/20 0.48
NPC1 O15118 9/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
SMN1; SMN2 Q16637 7/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
TP53 P04637 5/20 0.45
POLB P06746 1/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
NR1H4 Q96RI1 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
ALDH1A1 P00352 1/20 0.43
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TUBB4A P04350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019255 0.88 NR1H4 (0.54) L3MBTL1RAB9ANPC1NFKB1NFKB2
SCHEMBL4227737 0.86 NR1H4 (0.56) L3MBTL1RAB9ANPC1NFKB1NFKB2
SCHEMBL7018242 0.82 L3MBTL1 (0.41) L3MBTL1RAB9ANPC1SMN1; SMN2TSHR
SCHEMBL14153091 0.80 TP53 (0.52) L3MBTL1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL4957967 0.79 NPC1 (0.52) L3MBTL1RAB9ANPC1SMN1; SMN2TSHR
SCHEMBL6609615 0.78 NPC1 (0.47) L3MBTL1RAB9ANPC1NFKB1NFKB2
SCHEMBL9485342 0.78 NPC1 (0.44) L3MBTL1RAB9ANPC1NFKB1NFKB2
SCHEMBL29176843 0.78 L3MBTL1 (0.44) L3MBTL1RAB9ANPC1SMN1; SMN2TSHR
SCHEMBL4958154 0.78 TP53 (0.52) L3MBTL1RAB9ANPC1SMN1; SMN2TP53
SCHEMBL28630172 0.77 SMN1; SMN2 (0.57) L3MBTL1RAB9ANPC1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5736555-A HYPOTENSIVE AGENTS; FDA ORANGE BOOK LISTED PATENT FOR AZILSARTAN MEDOXOMIL TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-07 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed